Management team

JOHN SCHELLHORN
President and CEO

Based in New Hampshire, USA, John is a 33-year veteran of the Medical Device industry. Ten of those years were spent in senior expatriate assignments. Before becoming President and CEO of GKC, he served as President and CEO of Monteris Medical Corporation. Prior to joining Monteris, John served as the Chief Commercialization Officer for BÂRRX Medical, and as President and CEO of Softscope Medical Technologies Inc., both of which were successfully acquired by strategic partners during his tenure. John has held positions as Vice President of Sales and Marketing for the Peripheral Vascular Division of ev3 Inc., Vice President and General Manager International for ACMI Corporation, and various management positions within Boston Scientific. John earned a B.A, Summa Cum Laude, from Long Island University and, prior to his commercial career, he served 7 years as a U.S. Marine Corps pilot.

BROOKE REN
Chief Operating Officer and GM China

Brooke brings over 25 years experience in the development of medical devices and has been deeply involved in the introduction of some of the most important product innovations in our industry, including the earliest advanced angioplasty balloons for use in interventional cardiology and the world’s first peripheral embolic protection device, Spyder, for which she received multiple patents for her work. It remains the industry standard to this day. Brooke also has extensive experience in China, where she has lead, as a consultant, GKCs entry strategy into this key market.

MICHELLE GOLDSMITH
Senior Vice President, Business Partnering & Strategy

Michelle has previously held senior roles within industry and Government, including extensive experience in policy and program design, and served for three years in various positions at the Australian Stem Cell Centre including Chief Operating Officer and Company Secretary, with specific responsibility for Business Development and Government Affairs. Michelle is a qualified lawyer and is based in Melbourne.

PETER LYNCH
Vice President, Clinical Affairs and Reimbursement

Global medical device reimbursement strategist Peter Lynch brings high value experience to GKC. A former Global Reimbursement Director at Medtronic, Peter has worked directly with a multitude of geographies including USA, Europe, Asia-Pacific, Latin America, MEA, China, India, Japan, & Australia. As Head of Global Market Access, Reimbursement and Health Economics, Peter plans and executes GKC’s reimbursement activities in different jurisdictions around the globe, seeking funding approvals from payers for the PKG™. Peter also drives payer-focused evidence development around the world to support the clinical and economic value of the PKG™. Peter is based in our USA office in Minneapolis.

BRENDAN FAFIANI
Vice President, Product Development

Brendan has a background in medical device development projects ranging from software to electronic auto-injectors and disposables. He has held positions in the global headquarters of Merck KGaA’s medical device division as a Project Manager and later Associate Director of Reliability, Support & Maintenance overseeing the lifecycle management of a large device portfolio. Prior to this, Brendan held various consulting roles in pharma with Eli Lilly and Serono. Brendan is Dutch, and has worked for several years in Ireland and Switzerland prior to relocating to Australia.

TERESA PREGO
SENIOR VICE PRESIDENT, MARKETING

Teresa brings over 25 years experience in healthcare marketing, product development and commercialization, working in both medical device and diagnostic companies, as well as with major healthcare provider networks and consulting firms. Teresa has held leadership roles with Medtech Surgical/Zimmer Biomet, Steward Healthcare System, Tenet Healthcare, Aspect Medical, Boston Scientific, CSA Medical and Bayer Diagnostics. Teresa has extensive experience launching and driving market adoption of innovative technologies into global markets.